Century Therapeutics 1 article

The core modality behind Century Therapeutics is iPSC-derived cell therapy; as an iPSC-derived off-the-shelf cell-therapy company, it also relies on off-the-shelf engineered immune cells to shape cellular function or delivery. Its platform also involves allogeneic natural killer cell therapeutics and gamma delta T-cell therapeutics, with CAR-engineered iPSC immune cells defining an important aspect of cell sourcing, genetic engineering, immune compatibility or ex vivo processing. For entity matching, engineered-cell methods are not synonyms for the company; Century Therapeutics is also associated with Allo-Evasion immune engineering.